Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure

Tafenoquine has been licensed for the single-dose radical cure of Plasmodium vivax in adults; however, it is only recommended in patients with > 70% of normal glucose-6-phosphate dehydrogenase (G6PD) activity. Because this may hinder widespread use, we investigated sex-based treatment strategies...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela Devine, Rosalind E. Howes, David J. Price, Kerryn A. Moore, Benedikt Ley, Julie A. Simpson, Sabine Dittrich, Ric N. Price
Other Authors: Melbourne School of Population and Global Health
Format: Article
Published: 2020
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/57960
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University